# A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis

> **NCT03132610** · PHASE4 · UNKNOWN · sponsor: **Jiangxi Qingfeng Pharmaceutical Co. Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Acute Exacerbation of Chronic Bronchitis

## Interventions

- **DRUG:** andrographolide sulfonate
- **DRUG:** andrographolide sulfonate simulation

## Key facts

- **NCT ID:** NCT03132610
- **Lead sponsor:** Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12-01
- **Primary completion:** 2017-12-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03132610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03132610, "A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03132610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*